NeurAxis (NRXS) Set to Release Earnings on Monday

NeurAxis (NASDAQ:NRXS) is expected to be posting its results before the market opens on Monday, November 9th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $2.10 million for the quarter.

NeurAxis Stock Performance

Shares of NASDAQ:NRXS opened at $7.13 on Monday. The firm has a market capitalization of $89.54 million, a PE ratio of -3.87 and a beta of 1.38. NeurAxis has a 52-week low of $2.21 and a 52-week high of $9.33. The firm has a fifty day moving average of $6.83 and a 200 day moving average of $6.63.

Analyst Ratings Changes

Separately, Zacks Research upgraded NeurAxis to a “hold” rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $13.00.

About NeurAxis

NeurAxis, Inc (NASDAQ: NRXS) is a medical technology company focused on developing and commercializing non-invasive neuromodulation therapies for functional gastrointestinal and other nervous-system-related disorders. The company’s approach is designed to influence neural signaling through targeted electrical stimulation.

NeurAxis’s principal product is IB-Stim, a prescription, percutaneous electrical nerve-field stimulation device intended for use in adolescents with functional abdominal pain associated with irritable bowel syndrome and related functional gastrointestinal disorders.